Related Experiment Videos
Dynamic Branching Virtual Simulation for Management of Medication-Induced Anaphylaxis by Pediatric Nurses: A Pilot
1Department of Pediatric Respiratory and Immunology Nursing, West China Second University Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China.
Journal of Continuing Education in Nursing
|July 14, 2026
Summary
A new virtual simulation effectively trained pediatric nurses in managing inpatient anaphylaxis. This simulation improved critical actions, including epinephrine administration, from 33% to 100%.
Area of Science:
- Pediatric Emergency Medicine
- Medical Simulation Technology
- Nursing Education
Background:
- Pediatric inpatient anaphylaxis demands rapid recognition and prompt epinephrine administration.
- A novel engine-driven virtual simulation was created for guided training and performance logging.
Purpose of the Study:
- To evaluate the feasibility and effectiveness of a virtual simulation for pediatric nurses.
- To assess improvements in time-critical actions during anaphylaxis management.
Main Methods:
- A unit-based educational evaluation involved 12 pediatric nurses.
- Participants completed baseline and post-training assessments using the simulation.
- System Usability Scale and log-derived performance metrics were analyzed.
Main Results:
- All nurses completed the training, with performance scores increasing from 9.7 to 15.5 (out of 20).
- Epinephrine administration rates improved significantly from 33% to 100%.
- The mean System Usability Scale score was 62.5, indicating good usability.
Conclusions:
- Engine-driven virtual simulation is feasible in routine clinical workflows.
- The simulation shows potential for improving critical actions in pediatric anaphylaxis management.
- Further refinement and broader evaluation are warranted.
Related Concept Videos
01:30Asthma-IV: Nursing Management
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
02:06Allergic Reactions
Overview
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:30Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...